Effect of recurrent growth of aspergillus on lung function in paediatric population with cystic fibrosis (CF)

A. Adams, R. Thursfield, A. Bush (London, United Kingdom)

Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Session: Cystic fibrosis: new basic, clinical and bacteriological knowledge
Session type: Poster Discussion
Number: 4564
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Adams, R. Thursfield, A. Bush (London, United Kingdom). Effect of recurrent growth of aspergillus on lung function in paediatric population with cystic fibrosis (CF). Eur Respir J 2011; 38: Suppl. 55, 4564

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Ciliary function in paediatric non cystic fibrosis (CF) lung transplant recipients
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009

Bacterial infection and lung function in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 615s
Year: 2005

The impact of Achromobacter xylosoxidans on lung function and hospital admissions in adult patients with cystic fibrosis (CF)
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


Improved survival at low lung function in cystic fibrosis (CF)
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009

The impact of colonization with therapy-resistant pathogens on the survival rate after lung transplantation (LUTX) in cystic fibrosis (CF)
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021



Factors affecting lung function in adult cystic fibrosis patients after lung transplantation.
Source: International Congress 2018 – Evolving approaches to differential diagnosis
Year: 2018



Progression of lung involvement in patients with cystic fibrosis (CF), assessed by longitudinal respiratory function measurements
Source: Eur Respir J 2002; 20: Suppl. 38, 20s
Year: 2002

Impact of sensitization to Aspergillus fumigatus on lung function in cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010


Prevalence of renal impairment in an adult cystic fibrosis (CF) centre
Source: Eur Respir J 2005; 26: Suppl. 49, 622s
Year: 2005

Comparison of progression in lung structure and lung function in children and adolescents with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 714s
Year: 2006

Update on management of lung infection in cystic fibrosis
Source: Virtual Congress 2020 – Updates in cystic fibrosis
Year: 2020


Evolution of the infectious disease in cystic fibrosis (CF)
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008


PP309 – Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis
Source: ERS Lung Science Conference 2021
Year: 2021

The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013

Comparison of lung function during infancy and childhood in children with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 229s
Year: 2003

Longitudinal changes in lung function and the association with pulmonary structure and infection in infants with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008

High frequency chest wall oscillation (HFCWO) in the treatment of acute pulmonary exacerbation in adult cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013


LSC - 2021 - Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021


The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects
Source: Eur Respir Rev, 30 (161) 210055; 10.1183/16000617.0055-2021
Year: 2021



The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013